Patent details

EP1644037 Title: FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)

Basic Information

Publication number:
EP1644037
PCT Application Number:
PCT/US/2004/022001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047860523
PCT Publication Number:
WO/2005/020889
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FUNCTIONAL INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
French Title of Invention:
PARTICULES PSEUDOVIRALES FONCTIONNELLES DE LA GRIPPE (VLP)
German Title of Invention:
FUNKTIONALE INFLUENZA-VIRUS-ÄHNLICHE TEILCHEN (VLPS)
SPC Number:

Dates

Filing date:
09/07/2004
Grant date:
28/12/2011
EP Publication Date:
28/12/2011
PCT Publication Date:
10/03/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/04/2006
EP B1 Publication Date:
28/12/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/07/2012
Expiration date:
09/07/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/07/2004
 
 

Name:
NOVAVAX INC.
Address:
8320 Guilford Road, Suite C, Columbia, MD 21046, United States (US)

Inventor

1

Name:
PUSHKO Peter, M.
Address:
United States (US)

2

Name:
ROBINSON Robin, A.
Address:
United States (US)

Priority

Priority Number:
617569
Priority Date:
11/07/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/145;
Filing date Document type Number of pages